<?xml version="1.0" encoding="UTF-8"?>
<ref id="B93-pharmaceuticals-12-00157">
 <label>93.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Barrows</surname>
    <given-names>N.J.</given-names>
   </name>
   <name>
    <surname>Campos</surname>
    <given-names>R.K.</given-names>
   </name>
   <name>
    <surname>Powell</surname>
    <given-names>S.T.</given-names>
   </name>
   <name>
    <surname>Prasanth</surname>
    <given-names>K.R.</given-names>
   </name>
   <name>
    <surname>Schott-Lerner</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Soto-Acosta</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Galarza-Mu√±oz</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>McGrath</surname>
    <given-names>E.L.</given-names>
   </name>
   <name>
    <surname>Urrabaz-Garza</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Gao</surname>
    <given-names>J.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>A screen of FDA-approved drugs for inhibitors of Zika virus infection</article-title>
  <source>Cell Host Microbe</source>
  <year>2016</year>
  <volume>20</volume>
  <fpage>259</fpage>
  <lpage>270</lpage>
  <pub-id pub-id-type="doi">10.1016/j.chom.2016.07.004</pub-id>
  <pub-id pub-id-type="pmid">27476412</pub-id>
 </element-citation>
</ref>
